Centessa Pharmaceuticals pulls off massive $225m deal—Stock price jumps
Centessa Pharmaceuticals has experienced a substantial rise in its share price after completing an upsized public offering of American Depositary Shares (ADSs). The company, listed ... Read More
Centessa Pharmaceuticals gets FDA orphan drug status for SerpinPC in hemophilia B
Centessa Pharmaceuticals has secured orphan drug designation from the US Food and Drug Administration (FDA) for SerpinPC in hemophilia B treatment. According to the UK-based ... Read More